Showing 1 - 5 results of 5 for search 'A Alexandrou', query time: 0.03s Refine Results
  1. 1
    Common Ancestry Is a Poor Predictor of Competitive Traits in Freshwater Green Algae.

    Common Ancestry Is a Poor Predictor of Competitive Traits in Freshwater Green Algae. by Anita Narwani, Markos A Alexandrou, James Herrin, Alaina Vouaux, Charles Zhou, Todd H Oakley, Bradley J Cardinale

    Published 2015-01-01
    Get full text
    Article
  2. 2
    P119: TRIAL IN PROGRESS: THE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 1B CROSSWALK-A TRIAL EVALUATING THE SAFETY OF CROVALIMAB FOR THE MANAGEMENT OF ACUTE UNCOMPLICATED VASO-OCCLUSIVE EPISODES (VOES) IN PATIENTS (PTS) WITH SICKLE CELL DISEASE (SCD)

    P119: TRIAL IN PROGRESS: THE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 1B CROSSWALK-A TRIAL EVALUATING THE SAFETY OF CROVALIMAB FOR THE MANAGEMENT OF ACUTE UNCOMPLICATED V... by P Bartolucci, K Ataga, M Callaghan, L De Franceschi, C Minniti, A Alexandrou, D Imbs, R Fox, H Patel, A Sostelly, J Schimmel

    Published 2022-01-01
    Get full text
    Article
  3. 3
    5610823 TRIAL IN PROGRESS: THE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 1B CROSSWALK-A TRIAL EVALUATING THE SAFETY OF CROVALIMAB FOR THE MANAGEMENT OF ACUTE UNCOMPLICATED VASO-OCCLUSIVE EPISODES (VOES) IN PATIENTS (PTS) WITH SICKLE CELL DISEASE (SCD)

    5610823 TRIAL IN PROGRESS: THE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 1B CROSSWALK-A TRIAL EVALUATING THE SAFETY OF CROVALIMAB FOR THE MANAGEMENT OF ACUTE UNCOMPLICATED... by P. Bartolucci, K.I. Ataga, M. Callaghan, L. De Franceschi, C. Minniti, A. Alexandrou, D.-.C. Imbs, R.P. Fox, H. Patel, A. Sostelly, J. Schimmel

    Published 2023-04-01
    Get full text
    Article
  4. 4
    5-year follow-up of the safety, tolerability and efficacy of subcutaneous trastuzumab for the adjuvant treatment of HER2-positive early breast cancer. Results from the SafeHER Phase III trial

    5-year follow-up of the safety, tolerability and efficacy of subcutaneous trastuzumab for the adjuvant treatment of HER2-positive early breast cancer. Results from the SafeHER Phas... by J. Gligorov, X. Pivot, B. Ataseven, M. De Laurentiis, A. Llombart, K.H. Jung, A. Manikhas, H.A. Azim, A. Alexandrou, K. Gupta, L. Herraez-Baranda, N. Tosti, E. Restuccia

    Published 2021-04-01
    Get full text
    Article
  5. 5
    Prehospital hypoxemia, measured by pulse oximetry, predicts hospital outcomes during the New York City COVID‐19 pandemic

    Prehospital hypoxemia, measured by pulse oximetry, predicts hospital outcomes during the New York City COVID‐19 pandemic by Elizabeth A. Lancet, Dario Gonzalez, Nikolaos A. Alexandrou, Benjamin Zabar, Pamela H. Lai, Charles B. Hall, James Braun, Rachel Zeig‐Owens, Douglas Isaacs, David Ben‐Eli, Nathan Reisman, Bradley Kaufman, Glenn Asaeda, Michael D. Weiden, Anna Nolan, Hugo Teo, Eric Wei, Shaw Natsui, Christopher Philippou, David J. Prezant

    Published 2021-04-01
    Get full text
    Article

Search Tools: